Objectives: Recent studies have suggested that survival following the Norwood procedure is influenced by anatomy and is worse for patients with hypoplastic left heart syndrome (HLHS), particularly aortic atresia (AA), as compared to other forms of functional single ventricle and systemic outflow tract obstruction. The current study was undertaken to evaluate our recent experience with the Norwood procedure and to evaluate potential predictors of operative and 1-year mortality. Methods: A retrospective study of risk factors for operative and 1-year mortality in 158 patients undergoing the Norwood procedure between January 1, 1998 and June 30, 2001. Results: HLHS was present in 102 patients (70 with AA) and other forms of functional single ventricle with systemic outflow tract obstruction in the remaining 56. Operative survival was 77% (122/158), 78% for patients with HLHS and 75% for patients with other diagnoses. Multivariable analysis identified birth weight (odds ratio (OR) 0.18/kg, 95% confidence limit (CL) 0.08-0.42, P , 0:001), associated cardiac anomalies (OR 4.45, 95% CL 1.50-13.2, P ¼ 0:001), total support time (OR 1.02/min, 95% CL 1.01-1.03, P ¼ 0:004), and extracorporeal membrane oxygenation (ECMO) or ventricular assist device (VAD) support (OR 17.8, 95% CL 4.40-71.0, P , 0:001) as predictors of operative mortality. The anatomic diagnosis (HLHS versus non-HLHS) was not a predictor of mortality, P ¼ 0:6). The Kaplan-Meier survival estimate at 1 year was 66% (95% CL 58-73%) and was not different for patients with HLHS compared to non-HLHS, P ¼ 0:5. For patients who have survived the Norwood procedure, survival to 1 year was 86% (95% CL 78-91%). Presence of an extra-cardiac anomaly or genetic syndrome (OR 2.70, 95% CL 0.98-7.41%, P ¼ 0:05) and presence of an additional cardiac defect (OR 3.99, 95% CL 1.67-9.57, P ¼ 0:002) were predictors of worse survival in the first year of life. Conclusions: The Norwood procedure is currently being applied to a heterogeneous group of patients. Operative and 1-year survival are equivalent for patients with HLHS and those with other cardiac defects. The presence of additional cardiac or extra-cardiac anomalies are predictors of poor outcome. q
Introduction
The Norwood procedure was introduced as first stage reconstructive surgery for patients with hypoplastic left heart syndrome (HLHS) and has subsequently been applied to many cardiac defects characterized by the presence of a functional single ventricle with systemic outflow tract obstruction [1] . Outcome following Norwood reconstruction has improved significantly secondary to modifications in the surgical technique, improved perioperative care, and improved anesthetic management [2, 3] . Despite the continuing improvement in outcomes, the early survival for patients with functional single ventricle and systemic outflow tract obstruction is significantly poorer than that for other cardiac defects which require neonatal repair. A variety of factors have been suggested as possible predictors of operative mortality including anatomic diagnosis, aortic atresia (AA), additional cardiac defects, low birth weight, prematurity, associated non-cardiac anomalies and genetic syndromes, and recently post-natal diagnosis of the cardiac defect [3] [4] [5] [6] [7] [8] [9] [10] . Recent studies also have suggested that the outcome following the Norwood procedure for HLHS, particularly AA, is worse than for other forms of single ventricle with systemic outflow tract obstruction [5, 10] . In addition to the increased operative mortality, there is a persistent incidence of death; often sudden and unexplained, during the first year of life among patients who survive the initial hospitalization [11] . The current study was undertaken to evaluate our recent institutional experience with the Norwood procedure in patients with HLHS and other forms of functional single ventricle with systemic outflow tract obstruction and to evaluate potential predictors of operative and 1-year mortality.
Methods
The cardiac surgery and cardiac intensive care unit databases of The Children's Hospital of Philadelphia were reviewed to identify all patients undergoing the Norwood procedure between January 1, 1998 and June 30, 2001 , as well as those with similar cardiac defects (functional single ventricle with systemic outflow tract obstruction) who did not undergo surgery. Anatomic diagnosis was based on review of echocardiography, operative findings, and autopsy reports. HLHS was defined as normal segmental anatomy {S,D,S}, intact ventricular septum, aortic and mitral atresia or stenosis, and hypoplasia of the left ventricle (LV). Patients with double outlet right ventricle, mitral atresia, and aortic arch obstruction were also considered to have HLHS. Patients with HLHS were further classified according to the presence or absence of AA. Other forms of functional single ventricle with systemic outflow tract obstruction, such as unbalanced atrioventricular canal defects (AVC) and single LV with transposition of the great arteries, were classified as non-HLHS (Table 1) . Follow-up status was determined by review of the medical records and contact with the referring cardiologist. The study was approved by the Institutional Review Board at The Children's Hospital of Philadelphia.
At our institution, patients with functional single ventricle and systemic outflow tract obstruction, including HLHS, undergo staged surgical reconstruction. Primary cardiac transplantation is not utilized. The Norwood procedure is performed in the neonatal period followed by superior cavopulmonary connection at approximately 6 months of age and a Fontan procedure at 18-24 months of age. Transplantation is reserved for patients who develop significant ventricular dysfunction or AV valve regurgitation and who are not candidates for further reconstructive surgery. Thus, need for eventual transplantation is not considered failure of the newborn treatment protocol. The Norwood procedure was performed by four surgeons and several modifications were utilized during the study period. A standard Norwood operation was defined as atrial septectomy, right modified Blalock-Taussig shunt, division of the main pulmonary artery with side-to-side anastomosis to the diminutive ascending aorta without aortic transection, and homograft patch augmentation of the ascending aorta and arch (Standard). In some patients, transection of both the aorta and pulmonary artery was performed with a side-toside anastomosis of the proximal divided vessels. The distal ascending aorta and arch were augmented with a homograft patch and an end-to-end anastomosis performed between the distal aorta and the proximal great vessels ('DoubleBarrel'). A variety of other techniques were each utilized in a small number of patients including direct anastomosis of the divided main pulmonary artery to the aortic arch, with or without anterior patch augmentation; use of a homograft tube interposition graft to connect the main pulmonary artery to the aortic arch, and conversion to a Norwood type operation following previous coarctation repair ('Other'). Repair of associated cardiac defects was performed as appropriate. Delayed sternal closure was not routinely used. Support with extracorporeal membrane oxygenation (ECMO) or a ventricular assist device (VAD) was utilized when the patient could not be separated from cardiopulmonary bypass (CPB) or during resuscitation following a cardiac arrest.
Statistical methods
Data were analyzed and compared for four groups of children: the entire cohort of children undergoing the Norwood procedure; the cohort of children who were operative survivors (survival to hospital discharge and at least 30 days post-operatively); the subgroup of children with HLHS; and in this subgroup, those with and without AA. Patient and operative variables were assessed as potential predictors of operative (hospital discharge and at least 30 days after surgery) and 1-year mortality ( Table 2 ). Data are presented as medians and ranges.
Data analysis involved three phases. Phase I consisted of computation and evaluation of basic descriptive statistics (e.g. central tendency, variability, association) to assist with the data exploration and understanding. Phase II consisted of two separate logistic regressions with operative survival as the outcome interest (one for the whole cohort of patients and the other for patients with HLHS only). Finally, Phase III of data analysis consisted of four separate survival analyses, all with 1-year survival as the outcome of interest: one analysis for the entire cohort of patients; one for the patients who survived the initial operation; one for patients with HLHS only; and, finally, one analysis for the subgroup of patients with HLHS who survived the initial operation. One-year survival estimates were obtained from the Kaplan-Meier model. For survival analysis, the date of birth was considered as time zero. Logistic models were tested for fit using traditional chi-square goodness-of-fit statistics with log likelihood and Wald tests serving as the basis for model comparisons. Similarly, Cox proportional hazard models were tested using chi-square goodness-of-fit statistics and groups were compared using the log-rank test for equality of functions. Results are expressed as odds ratio (OR) with 95% confidence limits (CL). All hypotheses were tested at the a ¼ 0:01 level. The experiment-wise error rate was held constant at the a ¼ 0:05 level using Westfall and Young's method for correlated endpoints [12] . Data were analyzed using STATA 7.0 (Stata Corporation 2000, College Station, TX, USA). The area under the receiver operating characteristic (ROC) curve is a measure of the predictive accuracy of the logistic model at different points of sensitivity and specificity (or 1 -specificity). The curve is generated by calculating the proportion of deaths predicted by the model among those who died as compared with the proportion of deaths predicted by the model among those who survived for different threshold values. Threshold values used in these ROC curves are determined by the predicted probabilities of death for each case in the logistic model. Thus, the area under the curve represents the probability that a randomly chosen predicted probability value from the death group exceeds that of a randomly chosen predicted probability value from the survivor group. The more a logistic model can distinguish between these groups, the closer the area under the ROC curve will be to one [13] .
Results
Between January 1, 1998 and June 30, 2001, 158 infants underwent the Norwood procedure at The Children's Hospital of Philadelphia. During the same time period, 11 children with suitable cardiac anatomy were admitted and did not undergo surgery because of multiple congenital anomalies or severe neurologic injury from a pre-hospital arrest. There were 98 males and 60 females. The median birth weight was 3075 g (range 1200-4625, n ¼ 156). Twenty-six children (16%) were born prematurely (gestational age ,37 weeks, range 28-36 weeks). A prenatal diagnosis of congenital heart disease had been made in 80 of the children (51%). HLHS was present in 102 patients (70 with AA) and other diagnoses in 56 patients ( Table 2 ). Significant associated cardiac lesions, excluding persistent left superior vena cava and interrupted inferior vena cava, were present in 33 children (21%) ( Table 3 ). Significant extra-cardiac anomalies or genetic syndromes were present in 23 patients (15%) ( Table 3 ). The median age at admission to our institution for the Norwood procedure was 1 day (range 1-145). Five patients underwent surgery prior to the Norwood procedure including atrial septectomy (2), coarctation repair (2), and coarctation repair with pulmonary artery banding (1) . During the study period, no other children underwent coarctation repair and pulmonary artery banding. The median age at the Norwood procedure was 5 days (range 1-156). Sixteen children (10%) were 14 days of age or greater at the time of surgery. The median weight at surgery was 3.04 kg (range 1.2-5.7). Thirty-seven children weighed 2.5 kg or less at the time of surgery (23%). Weight less than or equal to 2.5 kg at the time of surgery and/or an associated anomaly (cardiac or extra-cardiac) was present in 73 patients (46%). A Standard Norwood procedure was performed in 115 patients, a 'Double-Barrel' procedure in 28 patients, and 'Other' types in 15 patients. The median total support time (CPB time 1 deep hypothermic circulatory arrest (DHCA) time) was 88 min (range 60-295). The median CPB time alone was 43 min (range 37-233). The median DHCA time was 44 min (range 1-116). The median myocardial ischemia time was 45 min (range 20-125). Delayed sternal closure was utilized in 38 patients (24%). ECMO or VAD support was utilized in 18 patients (11%).
Operative mortality
The overall operative mortality was 36 patients (23%). Hospital survival for patients with HLHS was 78% (80/102) and for non-HLHS patients was 75% (42/56). Among the sub-group of patients with HLHS, survival for patients with AA was 74% (52/70) and for patients with aortic stenosis was 87% (28/32). Hospital survival for patients weighing 2.5 kg or less at the time of surgery was 62% (23/37), compared to 82% (99/121) for patients who weighed greater than 2.5 kg. Hospital survival for patients with low weight at the time of surgery (,2.5 kg) and/or an associated anomaly (cardiac or extra-cardiac) was 73% (53/73) compared to 88% (75/85) for patients weighing greater than 2.5 kg with no associated anomaly. Since January 1, 2000, mortality for this low-risk group has been 8% (3/38). Prenatal diagnosis of congenital heart disease did not alter hospital survival which was 77% (62/80) for patients with a prenatal diagnosis of congenital heart disease, compared to 77% (60/ 78) for those with a post-natal diagnosis.
Logistic regression models
In the multivariable analysis for the entire cohort, the only characteristics which were associated with an increased risk of operative death were lower birth weight, an associated cardiac anomaly, longer total support time, and ECMO or VAD support (Table 2) . Birth weight and weight at surgery was similar for the cohort; however, inclusion of birth weight resulted in a better fit of the model. Anatomic diagnosis (HLHS versus non-HLHS) was not a predictor of mortality ðP ¼ 0:6Þ. The area under ROC curve yielded a predictive accuracy of 87%. In the multivariable analysis for the HLHS patients alone ðn ¼ 102Þ, the only characteristics which increased the risk of operative death were lower birth weight, longer total support time, and ECMO or VAD support (Table 4 ). The presence of AA was not a predictor of operative death ðP ¼ 0:3Þ. The area under the ROC curve yielded a predictive accuracy of 89%.
Follow-up
Orthotopic cardiac transplantation was performed during the first year following the Norwood procedure in three patients.
There were 15 deaths during the first year of life among the 122 children (12%) who survived the Norwood procedure; 11 occurred prior to the superior cavopulmonary connection, one at the time of the superior cavopulmonary connection at another institution, and three following superior cavopulmonary connection. Among the 11 deaths prior to superior cavopulmonary connection; eight were sudden unexplained cardiac deaths, one was secondary to respiratory syncitial viral infection, one occurred during readmission for shunt revision, and one was secondary to a cerebrovascular accident following cardiac catheterization. Among the three deaths following superior cavopulmonary connection; two were sudden unexplained deaths and one occurred during readmission for take-down of the superior cavopulmonary connection. (1) Other (4) a More than one additional lesion was present in two children.
Survival analysis
For the entire cohort, the Kaplan-Meier survival estimate at 1 year was 66% (95% CL 58-73%) (Fig. 1 ). Survival at 1 year was not different for patients with HLHS (64%, 95% CL 54-73%) compared to non-HLHS (68%, 95% CL 54-79%), P ¼ 0:6 (Fig. 2) . In the multivariable analysis, the characteristics which predicted mortality in the first year of life for the entire cohort were lower birth weight, an associated cardiac anomaly, an extra-cardiac anomaly or genetic syndrome, longer total support time, and ECMO or VAD support (Table 5 ). Among the HLHS cohort, characteristics which predicted 1-year mortality were similar; lower birth weight, an extra-cardiac anomaly, longer total support time, and ECMO or VAD support (Table 5 ). In the univariable analysis, there was lower survival at 1 year for patients with AA (57%, 95% CL 44-68%), compared to those without AA (81%, 95% CL 62-91%), P ¼ 0:05. However, in the multivariable analysis, AA was not a predictor of mortality ðP ¼ 0:3Þ. Survival to 1 year of age was significantly greater for patients weighing .2.5 kg at the time of the Norwood procedure without an associated anomaly (cardiac and/or extra-cardiac) (82%, 95% CL 71-89%), compared to the survival of patients with weight #2.5 kg and/or an associated anomaly (cardiac and/or extra-cardiac) (48%, 95% CL 35-59%), P ¼ 0:0003 (Fig. 3) .
For patients who survived the Norwood procedure, survival to 1 year was 86% (95% CL 78-91%). The only characteristic which predicted 1-year mortality in the early survivors were an additional cardiac defect (OR 3.99, 95% CL 1.67-9.57, P ¼ 0:002) or an extra-cardiac anomaly or genetic syndrome (OR 2.70, 95% CL 0.98-7.41%, P ¼ 0:05). Anatomic diagnosis was not a predictor of 1-year mortality. For the HLHS patients who survived the initial surgery, survival to 1 year was 83% (95%CL 72-90%) and 92% (95% CL 76-97%) for non-HLHS patients, P ¼ 0:2. The only predictor of mortality during the first year of life for the HLHS patients who survived the initial procedure was an extra-cardiac anomaly or genetic syndrome (OR 5.27, 95% CL 1.12-24.7, P ¼ 0:035).
Discussion
The current study demonstrates that the Norwood procedure is being applied to a heterogeneous patient population and outcomes continue to improve. The overall hospital survival was 77%, despite a patient population with either low weight at the time of surgery and/or an associated anomaly (cardiac or extra-cardiac) present in 73 patients (46%). Operative survival for patients without these risk factors was 88%, compared to 73% for those with one or more risk factors. During the study period, only 11 patients presenting to our hospital with a suitable cardiac defect did not undergo surgery suggesting that patients previously not considered to be operative candidates are now undergoing the Norwood procedure. Hospital survival for the patients with no significant associated anomalies now approaches that for other forms of critical congenital heart disease which require surgical repair in the neonatal period, such as interrupted aortic arch, truncus arteriosus, and pulmonary atresia with intact ventricular septum. Although anatomic diagnosis (HLHS versus non-HLHS) was not a risk factor, the presence of an associated cardiac defect was a predictor of operative mortality. As in previous studies, lower weight remains a risk factor for operative mortality, although the outcome appears to be improving. A prenatal diagnosis of the cardiac defect did not decrease the mortality risk, consistent with previous studies from our institution [14] . In addition to patient characteristics which increased risk, operative factors such as prolonged total support time and the need for ECMO or VAD were associated with an increased risk of death in the multivariable analysis. The early and late outcomes for children presenting with functional single ventricle and systemic outflow tract obstruction, including HLHS, have improved significantly since the introduction of the Norwood procedure. Mahle et al. [2] reported outcomes of 840 patients who underwent the Norwood procedure for HLHS between 1984 and 1999. The overall 1-year survival was 51%, however, there was a significant improvement in the mortality associated with the Norwood procedure in recent years. Later year of surgery was associated with significantly improved survival. Operative survival for the period 1995-1998 was 71.4%. Anatomic subtype was not a risk factor for death. Clancy et al. [8] assessed pre-operative predictors of operative mortality in a large group of neonates with congenital heart disease. Patients with functional single ventricle and systemic outflow tract obstruction had an increased operative mortality (26%), compared to other defects. Predictors of mortality in this group included presence of a genetic syndrome, decreased Apgar score, and increased age at hospital admission.
Many factors are likely responsible for the improvement in operative survival following the Norwood procedure including improved surgical techniques, improved perioperative management, and improved anesthetic techniques. Despite the improving outcome, early survival for these children is still significantly lower than for other forms of heart disease, which require neonatal surgical intervention. Factors which have been identified in multiple studies as potential predictors of mortality include low weight; presence of associated extra-cardiac defects or chromosomal abnormalities; presence of additional cardiac defects such as obstructed pulmonary venous drainage, total anomalous pulmonary venous connection, anomalous origin of the right subclavian artery; as well as operative factors such as prolonged CPB time [3] [4] [5] [6] [7] [8] [9] [10] . Unlike the current study, some studies have suggested that the cardiac diagnosis remains a risk factor with less favorable outcomes for patients with HLHS as compared to other cardiac defects. Daebritz et al. [5] compared the results of the Norwood operation for patients with HLHS and those with other malformations in 194 patients who underwent surgery between 1990 and 1998. One hundred thirty-one patients had HLHS and 63 patients had other defects. In this study, the operative mortality was significantly greater for patients with HLHS (37%) compared to those with other defects (19%). One-year survival was also significantly lower for patients with HLHS (51%) compared to patients with other defects (71%). There was no difference in survival between the anatomic subgroups in the HLHS patients.
Low weight at the time of surgery has been identified as a predictor of mortality [3, 4] . In 1999, Weinstein reported outcome following the Norwood procedure for 67 patients weighing #2.5 kg at the time of surgery between 1990 and 1997 with an operative mortality of 51% [4] . No variable could be correlated with increased mortality, although there was a trend toward increased mortality with increased CPB time and decreased ventricular function. The hospital survival for low weight infants of 62% in the current study suggests that the prognosis may be improving.
Of concern is the persistent incidence of death during the first year of life among patients who survived the initial hospitalization. In the current study, 12% of the survivors of the initial procedure died prior to 1 year of age, most before superior cavopulmonary connection. These deaths are usually sudden and often unexplained. Mahle et al. [11] evaluated the incidence of unexpected death among 536 patients with HLHS who survived the Norwood procedure. Unexpected death occurred in 4.1% of this large group of patients (22/536) at a median age of 79 days. A multivariable analysis demonstrated that perioperative arrhythmias and earlier era of surgical procedure were associated with an increased risk for unexpected death. No anatomic subtypes were found to be risk factors for death. In the current study, most of the late deaths occurred prior to the superior cavopulmonary connection; while mortality for this procedure is itself very low, 1/92 (1.1%). Multiple factors may be responsible for the unexplained deaths, including coronary insufficiency, arrhythmia, ventricular dysfunction, residual arch obstruction, pulmonary artery distortion, restrictive atrial septal defect, and inadequate pulmonary blood flow. However, in the current study, the only predictor of mortality in the first year of life for those who survived the Norwood procedure was the presence of associated anomalies (either cardiac or extra-cardiac). There was no difference in 1-year survival between patients with HLHS and other cardiac defects, however, there was a trend toward poorer survival for patients with AA as is reported in other studies. In the current study, AA was not a predictor of mortality in the multivariable analysis suggesting it is linked to other risk factors such as lower birth weight or associated anomalies. Patients with AA may be at risk for sudden death, secondary to the lack of antegrade aortic flow and abnormal coronary artery flow patterns. Some studies have suggested that patients with smaller ascending aortas have a worse outcome [6, 7] . As operative survival continues to improve, it is important to identify patients at increased risk for death after hospital discharge and determine if modification of the treatment protocol can improve survival.
Associated cardiac defects have also been identified as risk factors for both operative and 1-year mortality in other studies as well [3] [4] [5] [6] [7] [8] [9] [10] . Unfortunately, not every study reports the same defects. In the current study, associated cardiac defects included interrupted aortic arch, anomalies of pulmonary venous connection, obstruction to pulmonary venous drainage, anomalous origin of a subclavian artery, and atrioventricular valvar regurgitation. All of these have been implicated in other studies as predictors of mortality. The finding that additional cardiac defects are risk factors for both operative and 1-year mortality suggests that cardiac transplantation could be a better treatment strategy for some of these patients. However, many of these patients, particularly those with obstruction to pulmonary venous drainage, are difficult to stabilize medically while awaiting transplantation. Because of the increasing scarcity of appropriate donor organs as well as the mortality and morbidity while waiting for an organ, it is not clear that a strategy of primary transplantation would result in an improved outcome. Interestingly, associated extra-cardiac anomalies and genetic syndromes were predictors of 1 year of survival but were not associated with increased operative mortality. Thus, even though these patients may survive the initial procedure, the mid-term outcome is less favorable. Changing surgical treatment protocols are unlikely to improve outcome for this subgroup of patients, as they do not alter the underlying syndrome.
There are several limitations to this study. The retrospective nature precludes identification of risk factors not entered into the model. The presence of an associated cardiac defect was a predictor of both operative and 1-year mortality, however, the number of patients with each defect is small and it is not possible to evaluate the impact of each defect individually. In addition, there is a trend toward worse outcomes for patients with AA, however, data on the actual size of ascending aorta is not available.
In conclusion, the Norwood procedure is currently being applied to a heterogeneous group of patients with variable results in certain subgroups. The early survival for patients undergoing the Norwood procedure continues to improve, especially for patients of normal birth weight without associated anomalies. There is no difference in operative or 1-year survival for patients with HLHS, compared to those with other forms of functional single ventricle and systemic outflow tract obstruction. Much of the mortality risk, both operative and during the first year, is due to patient-related, rather than procedure-related variables, over which the medical and surgical teams have little control. The outcome for low birth weight infants has improved, but low weight remains a risk factor for mortality. In low-risk patients (i.e. those weighing .2.5 kg without additional cardiac or noncardiac anomalies), the early risk of surgery is 8%, which is similar to other forms of critical heart disease requiring newborn surgical management. As operative survival following the Norwood procedure continues to improve, it is difficult to justify either non-intervention or primary transplantation. Inter-stage mortality remains a concern. The most important predictors of a poor outcome in the first year of life for patients who survive the initial hospitalization are the presence of additional cardiac or extracardiac defects. Additional studies are necessary to determine if changes in management strategy or patient selection may reduce this risk.
